Back to Search
CHRISTINA DRAKE, FNP-BC
FNP-BC
Family Nurse Practitioner
NPI: 1245987833IndividualAccepts Medicare
Education
OTHER
Class of 2021
Clinical Trials (2)
2
Linked Trials
0
Recruiting
2
With Results
Study to Compare the Awakening Threshold Effects of Belsomra 10 mg and 20 mg to Placebo in Non-elderly Insomniacs
NCT03312517COMPLETEDPHASE4PRINCIPAL_INVESTIGATOR
Assess the Effect of Zolpidem, Silenor & Placebo on Arousability, Ataxia/Balance & Cognition in Healthy Volunteers
NCT02353299COMPLETEDPHASE4PRINCIPAL_INVESTIGATOR
Research & Publications (14)
Can the Orexin Antagonist Suvorexant Preserve the Ability to Awaken to Auditory Stimuli While Improving Sleep?
PMID 31538599·J Clin Sleep Med·2019
2-rct
Update on Psychotropic Drug Prescribing in the United States: 2014-2015.
PMID 29215384·J Clin Psychopharmacol·2018
8-other
Arousability and Fall Risk During Forced Awakenings From Nocturnal Sleep Among Healthy Males Following Administration of Zolpidem 10 mg and Doxepin 6 mg: A Randomized, Placebo-Controlled, Four-Way Crossover Trial.
PMID 28575467·Sleep·2017
8-other
Inhibition of Orexin Signaling Promotes Sleep Yet Preserves Salient Arousability in Monkeys.
PMID 26943466·Sleep·2016
7-preclinical
Orexin receptor antagonist-induced sleep does not impair the ability to wake in response to emotionally salient acoustic stimuli in dogs.
PMID 24904334·Front Behav Neurosci·2014
8-other
Safety and efficacy of suvorexant during 1-year treatment of insomnia with subsequent abrupt treatment discontinuation: a phase 3 randomised, double-blind, placebo-controlled trial.
PMID 24680372·Lancet Neurol·2014
3-trial
Orexin receptor antagonism for treatment of insomnia: a randomized clinical trial of suvorexant.
PMID 23197752·Neurology·2012
4-observational
The orexin antagonist SB-649868 promotes and maintains sleep in men with primary insomnia.
PMID 22851805·Sleep·2012
4-observational
Prospective study of obstructive sleep apnea and incident coronary heart disease and heart failure: the sleep heart health study.
PMID 20625114·Circulation·2010
8-other
Validation of the self-completed Cambridge-Hopkins questionnaire (CH-RLSq) for ascertainment of restless legs syndrome (RLS) in a population survey.
PMID 19195928·Sleep Med·2009
4-observational
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Request Appointment
This provider isn't set up for online booking yet. Once you submit, we'll reach out to their office to arrange secure delivery of your request.
Contact & Hours
Via practice · 2 locations total
- Address
- 7794 5 MILE RD
CINCINNATI, OH 45230 - Phone
- (513) 862-4957
Quick Facts
- NPI
- 1245987833
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 2
- Years in Practice
- 5
- Clinical Trials
- 2
- Publications
- 14
Are you this provider?
Claim Your Profile